[HTML][HTML] Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer

EB Eruslanov, PS Bhojnagarwala… - The Journal of …, 2014 - Am Soc Clin Investig
EB Eruslanov, PS Bhojnagarwala, JG Quatromoni, TL Stephen, A Ranganathan…
The Journal of clinical investigation, 2014Am Soc Clin Investig
Infiltrating inflammatory cells are highly prevalent within the tumor microenvironment and
mediate many processes associated with tumor progression; however, the contribution of
specific populations remains unclear. For example, the nature and function of tumor-
associated neutrophils (TANs) in the cancer microenvironment is largely unknown. The goal
of this study was to provide a phenotypic and functional characterization of TANs in
surgically resected lung cancer patients. We found that TANs constituted 5%–25% of cells …
Infiltrating inflammatory cells are highly prevalent within the tumor microenvironment and mediate many processes associated with tumor progression; however, the contribution of specific populations remains unclear. For example, the nature and function of tumor-associated neutrophils (TANs) in the cancer microenvironment is largely unknown. The goal of this study was to provide a phenotypic and functional characterization of TANs in surgically resected lung cancer patients. We found that TANs constituted 5%–25% of cells isolated from the digested human lung tumors. Compared with blood neutrophils, TANs displayed an activated phenotype (CD62LloCD54hi) with a distinct repertoire of chemokine receptors that included CCR5, CCR7, CXCR3, and CXCR4. TANs produced substantial quantities of the proinflammatory factors MCP-1, IL-8, MIP-1α, and IL-6, as well as the antiinflammatory IL-1R antagonist. Functionally, both TANs and neutrophils isolated from distant nonmalignant lung tissue were able to stimulate T cell proliferation and IFN-γ release. Cross-talk between TANs and activated T cells led to substantial upregulation of CD54, CD86, OX40L, and 4-1BBL costimulatory molecules on the neutrophil surface, which bolstered T cell proliferation in a positive-feedback loop. Together our results demonstrate that in the earliest stages of lung cancer, TANs are not immunosuppressive, but rather stimulate T cell responses.
The Journal of Clinical Investigation